Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-09
DOI
10.1038/s41388-020-01621-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MiR-450a-5p strengthens the drug sensitivity of gefitinib in glioma chemotherapy via regulating autophagy by targeting EGFR
- (2020) Yu Liu et al. ONCOGENE
- PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses
- (2019) Sayantani Sarkar Bhattacharya et al. Cell Death & Disease
- PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells
- (2019) Siyuan Yan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase II, 2‐stage, 2‐arm, PIK3CA mutation stratified trial of MK‐2206 in recurrent endometrial cancer
- (2019) Andrea P. Myers et al. INTERNATIONAL JOURNAL OF CANCER
- Endometrial cancer: Molecular markers and management of advanced stage disease
- (2018) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4
- (2018) Wenzhi Jia et al. ONCOGENE
- Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
- (2018) Susmita Mondal et al. INTERNATIONAL JOURNAL OF CANCER
- Distinct molecular landscapes between endometrioid and nonendometrioid uterine carcinomas
- (2017) Nathaniel L. Jones et al. INTERNATIONAL JOURNAL OF CANCER
- Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma
- (2017) Hui-Min Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
- (2016) Anna Rita Cantelmo et al. CANCER CELL
- Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)
- (2016) Günter Emons et al. GYNECOLOGIC ONCOLOGY
- Stress management by autophagy: Implications for chemoresistance
- (2016) Zhao Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Endometrial cancer
- (2016) Philippe Morice et al. LANCET
- Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation
- (2015) Meng-Meng Ji et al. Autophagy
- Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy
- (2015) Anna Shteingauz et al. CANCER RESEARCH
- Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51
- (2015) Ambber Ward et al. CANCER TREATMENT REVIEWS
- mTOR: a pharmacologic target for autophagy regulation
- (2015) Young Chul Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
- (2015) Deok-Beom Jung et al. Oncotarget
- Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth
- (2015) Ashwani Khurana et al. Oncotarget
- In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation
- (2015) Maria Angelica Cortez et al. Molecular Therapy-Nucleic Acids
- Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer
- (2014) Daliah Tsoref et al. GYNECOLOGIC ONCOLOGY
- The Warburg effect: molecular aspects and therapeutic possibilities
- (2014) Hanh Ngo et al. MOLECULAR BIOLOGY REPORTS
- Suppression of Feedback Loops Mediated by PI3K/mTOR Induces Multiple Overactivation of Compensatory Pathways: An Unintended Consequence Leading to Drug Resistance
- (2014) E. Rozengurt et al. MOLECULAR CANCER THERAPEUTICS
- Self-consumption: the interplay of autophagy and apoptosis
- (2014) Guillermo Mariño et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO
- (2013) I Ray-Coquard et al. BRITISH JOURNAL OF CANCER
- Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
- (2013) Katrien De Bock et al. CELL
- Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis
- (2013) Sandra Schoors et al. Cell Metabolism
- Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer
- (2013) B. F. Clem et al. MOLECULAR CANCER THERAPEUTICS
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
- (2012) B. M. Slomovitz et al. CLINICAL CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents
- (2010) K. M. Moxley et al. ONCOLOGIST
- Identification of novel autophagy regulators by a luciferase-based assay for the kinetics of autophagic flux
- (2009) Thomas Farkas et al. Autophagy
- The Double-Edged Sword of Autophagy Modulation in Cancer
- (2009) E. White et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started